Liva named Most Innovative HealthTech Company of the Year

It’s been a fantastic year so far for Liva Healthcare. In just nine months we have been shortlisted for seven awards, winning two, with more yet to be announced. Our proven results in halting the progression of, or reversing chronic conditions has been recognised by the Health Investor, Forward Healthcare, Health Technology Newspaper and European Lifestars Awards – phew!

The highlights

We began the year with a spot on the Digital Leaders 100 List, shortlisting us as Healthtech Innovation of the Year, then snapped up two awards at this year’s Global Health and Pharma Healthcare & Pharmaceutical Awards. Featuring alongside the biggest players in the health and pharma sector such as Medovate, and Carelinelive, Liva Healthcare was awarded ‘Most Innovative HealthTech Company of the Year’ and ‘Lifestyle & Disease Management Platform of the Year’ – a huge achievement for our team.

Liva Healthcare was not only shortlisted for awards in Europe. This year, we have also made the shortlist for the inaugural University of California San Francisco (UCSF) Digital Awards, for the ‘Best Employer Wellness & Prevention Company’. The UCSF Digital Health Awards recognise achievements in the growing field of digital health, which has increased to a nearly $7 billion industry in the United States.

Looking forward

These award wins are a further testament to the fact that our digital platform is a key driver for change in the healthcare market. In the last year, we have been widening our presence internationally through building new partnerships and launching new health prevention programmes. We are working with private insurance, pharma and public healthcare bodies globally to drive patient engagement, clinical outcomes and healthcare delivery efficiency with real-time data insight. Working with an international team of experts from the UK, Ireland, Australia and Denmark, to advance the care of patients. With more exciting projects expected later this year we look forward to the rest of 2019 and beyond.

Share:

Related articles